Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study ; volume:24 ; number:1 ; day:13 ; month:7 ; year:2024 ; pages:1-12 ; date:12.2024
BMC gastroenterology ; 24, Heft 1 (13.7.2024), 1-12, 12.2024

Creator
Shi, Yali
Feng, Wanlin
Cai, Jiaman
Wang, Zhonglin
Pu, Ying
Mao, Weiting
Zhan, Ke
Chen, Daorong
Contributor
SpringerLink (Online service)

DOI
10.1186/s12876-024-03322-8
URN
urn:nbn:de:101:1-2410020928091.270693988781
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Shi, Yali
  • Feng, Wanlin
  • Cai, Jiaman
  • Wang, Zhonglin
  • Pu, Ying
  • Mao, Weiting
  • Zhan, Ke
  • Chen, Daorong
  • SpringerLink (Online service)

Other Objects (12)

Transient portal vein thrombosis in liver cirrhosis

Transient portal vein thrombosis in liver cirrhosis

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis

Analysis of related factors of portal vein thrombosis in liver cirrhosis

Analysis of related factors of portal vein thrombosis in liver cirrhosis

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis

Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers

Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers

Management of Nonmalignant Portal Vein Thrombosis in Cirrhosis

Management of Nonmalignant Portal Vein Thrombosis in Cirrhosis

Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis

Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis

Differentiation of malignant from non-malignant portal vein thrombosis in liver cirrhosis: the challenging dilemma

Differentiation of malignant from non-malignant portal vein thrombosis in liver cirrhosis: the challenging dilemma

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Portal vein thrombosis after donor liver biopsy: Case report

Portal vein thrombosis after donor liver biopsy: Case report

HOXD9 regulated mitophagy to promote endothelial progenitor cells angiogenesis and deep vein thrombosis recanalization and resolution

HOXD9 regulated mitophagy to promote endothelial progenitor cells angiogenesis and deep vein thrombosis recanalization and resolution

Related objects